Search research articles
Contact Us
Filters
Showing results (171-180 of 361) with videos related to
Page
of 37
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 28, 2019
Linear IgA Disease of the Gingiva Following Nivolumab Therapy
Sushma Jonna, Mirdza Neiders, Suresh Lakshmanan, et al.
JAMA Network Open
|
May 25, 2022
Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Sanjay Popat, Stephen V Liu, Nicolas Scheuer, et al.
Nature Communications
|
June 17, 2022
Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer
Sanjay Popat, Stephen V Liu, Nicolas Scheuer, et al.
Epilepsia
|
July 26, 2014
Improved mapping of interictal epileptiform discharges with EEG-fMRI and voxel-wise functional connectivity analysis
Junjie V Liu, Erik J Kobylarz, Terrance M Darcey, et al.
Clinical Lung Cancer
|
June 1, 2022
Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy
Ishani Joshi, Monica Peravali, Xue Geng, et al.
Oncogene
|
August 11, 2018
Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer
In-Kyu Kim, Justine N McCutcheon, Guanhua Rao, et al.
The Journal of Biological Chemistry
|
June 15, 2007
Spermidine/spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1alpha
Jin Hyen Baek, Ye V Liu, Karin R McDonald, et al.
Annals of Translational Medicine
|
December 5, 2022
Classical <i>ALK</i> G1202R resistance mutation was identified in a lung adenocarcinoma patient with rare <i>LOC388942-ALK</i> fusion after sequential treatment with ALK-TKIs and anlotinib: a case report
Xiaoqian Zhai, Yanyang Liu, Zuoyu Liang, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research
|
December 22, 2007
Synergistic effects in apoptosis induction by taurolidine and TRAIL in HCT-15 colon carcinoma cells
A M Chromik, A Daigeler, C Hilgert, et al.
Cell Transplantation
|
January 1, 1994
Development and implementation of delivery and quality control system for cellular therapies: experience in 500 patients
F Miesowicz, G du Moulin, V Liu, et al.
Page
of 37
Search research articles
Search
Showing results (171-180 of 361) with videos related to
Sort By:
Page
of 37
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 28, 2019
Linear IgA Disease of the Gingiva Following Nivolumab Therapy
Sushma Jonna, Mirdza Neiders, Suresh Lakshmanan, et al.
JAMA Network Open
|
May 25, 2022
Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Sanjay Popat, Stephen V Liu, Nicolas Scheuer, et al.
Nature Communications
|
June 17, 2022
Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer
Sanjay Popat, Stephen V Liu, Nicolas Scheuer, et al.
Epilepsia
|
July 26, 2014
Improved mapping of interictal epileptiform discharges with EEG-fMRI and voxel-wise functional connectivity analysis
Junjie V Liu, Erik J Kobylarz, Terrance M Darcey, et al.
Clinical Lung Cancer
|
June 1, 2022
Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy
Ishani Joshi, Monica Peravali, Xue Geng, et al.
Oncogene
|
August 11, 2018
Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer
In-Kyu Kim, Justine N McCutcheon, Guanhua Rao, et al.
The Journal of Biological Chemistry
|
June 15, 2007
Spermidine/spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1alpha
Jin Hyen Baek, Ye V Liu, Karin R McDonald, et al.
Annals of Translational Medicine
|
December 5, 2022
Classical <i>ALK</i> G1202R resistance mutation was identified in a lung adenocarcinoma patient with rare <i>LOC388942-ALK</i> fusion after sequential treatment with ALK-TKIs and anlotinib: a case report
Xiaoqian Zhai, Yanyang Liu, Zuoyu Liang, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research
|
December 22, 2007
Synergistic effects in apoptosis induction by taurolidine and TRAIL in HCT-15 colon carcinoma cells
A M Chromik, A Daigeler, C Hilgert, et al.
Cell Transplantation
|
January 1, 1994
Development and implementation of delivery and quality control system for cellular therapies: experience in 500 patients
F Miesowicz, G du Moulin, V Liu, et al.
Page
of 37